Sitawalk M 100/500 PR Tablets

Sitawalk M 100/500 PR is a combination of Sitagliptin Phosphate Monohydrate (100 mg) and Metformin Hydrochloride Prolonged Release (500 mg). This medicine is prescribed to manage Type 2 Diabetes Mellitus, helping to control blood sugar levels effectively. The dual action of Sitagliptin and Metformin ensures improved glycemic control with a prolonged release mechanism for better patient compliance.

Composition (per tablet):

• Sitagliptin Phosphate Monohydrate eq. to Sitagliptin – 100 mg

• Metformin Hydrochloride (Prolonged Release) – 500 mg

• Excipients – q.s.

Pack Size: 10 x 10 Tablets (Box of 100 Tablets)
MRP: ₹1400/Box
GST: 12%

Key Benefits:

• Helps in managing Type 2 Diabetes Mellitus

• Improves insulin sensitivity and glucose tolerance

• Prolonged release for steady blood sugar control

• Reduces risk of diabetes-related complications

⚠️ Note: Use only under the guidance of a registered medical practitioner.

Franchise Welcome

Biophar Lifesciences Pvt. Ltd. invites dedicated pharma professionals and entrepreneurs to join hands with us through our Pharma Franchise / PCD Pharma opportunities. With a wide range of quality-assured medicines, strong marketing support, monopoly rights, and timely delivery, we provide an excellent platform to start and grow your pharmaceutical business. Partner with us today and become a part of India’s fastest-growing healthcare network.